BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2002
View Archived Issues
Landmark LIPS trial demonstrates significant reduction in risk of cardiac events on fluvastatin
Read More
Rationally designed anticancer drugs targeting key enzymes as a new approach to breast cancer
Read More
OCTAVE and OVERTURE results for Vanlev disclosed by BMS
Read More
HSV-1 glycoprotein D vaccine affords high and sustained protective immunity in animal models
Read More
Pharmacokinetics, oral bioavailability of potential new agent for HCMV
Read More
Xoma summarizes highlights of 2001
Read More
Anti-TNF antibodies prepared by scientists at Centocor
Read More
Vaccine for West Nile virus highly effective in mice, slated for clinical trials this year
Read More
Centocor patents series of anti-IL-12 antibodies
Read More
Compounds for cancer gene therapy reported by Fujisawa
Read More
Investigators at Shiseido identify new MMP inhibitors
Read More
Inhibitors of IL-1beta production synthesized at Kowa
Read More
Research at Ono leads to the design of new PDE4 inhibitors
Read More
Aventis discloses compounds active against telomerase
Read More
NeoTherapeutics presents summary of 2001 results
Read More
American College of Cardiology meeting highlights available to Daily Essentials readers
Read More
FDA advisory committee votes against recommending approval of Picovir
Read More
Canadian IND approval for buccal morphine in the treatment of pain
Read More
Phase III open-label study of Alprox-TD begins in male erectile dysfunction
Read More
Multiple phase III trials initiated for NBI-34060 in insomnia
Read More
Irofulven tested in cancer patients in combination with cisplatin
Read More
Antares Pharma and MacroMed team up to develop depot delivery systems
Read More
Alliance and Inhale expand PulmoSpheres agreement
Read More
